Innovate UK - Biomedical Catalyst

MODERATE Tx Startup

Strategy Notes

Good sector alignment—computational therapeutics for drug resistance fits the programme's life sciences scope. However, applicant prioritises Île-de-France/EU, and UK-focus is secondary on their roadmap. Critical unknowns: eligibility for pre-incorporated ventures, non-UK founders, and whether funding range matches their €30K–€2.5M target.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · The lead organisation must be a UK-registered SME (micro, small or medium enterprise) and all funded project work must be carried out in the UK with intent to exploit results from or in the UK. Eniola's venture is not yet incorporated and she plans to incorporate in Île-de-France/EU, not the UK — this is a hard structural blocker that cannot be waived.